Related references
Note: Only part of the references are listed.Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration
Thomas Carlsson et al.
BRAIN (2009)
Clinical Pattern and Risk Factors for Dyskinesias Following Fetal Nigral Transplantation in Parkinson's Disease: A Double Blind Video-Based Analysis
C. Warren Olanow et al.
MOVEMENT DISORDERS (2009)
Transplanted Dopaminergic Neurons Develop PD Pathologic Changes: A Second Case Report
Jeffrey H. Kordower et al.
MOVEMENT DISORDERS (2008)
Assessing fetal nerve cell grafts in Parkinson's disease
Heiko Braak et al.
NATURE MEDICINE (2008)
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
Ivar Mendez et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
The partial 5-HT1A agonist buspirone reduces the expression and development of I-DOPA-induced dyskinesia in rats and improves I-DOPA efficacy
Karen L. Eskow et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease
Thomas Carlsson et al.
JOURNAL OF NEUROSCIENCE (2007)
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats
Manolo Carta et al.
BRAIN (2007)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters
Kazuya Kannari et al.
NEUROSCIENCE LETTERS (2006)
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
P Piccini et al.
BRAIN (2005)
Regional distribution of serotonin transporter protein in postmortem human brain - Is the cerebellum a SERT-free brain region?
SJ Kish et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake
SN Saldaña et al.
NEUROSCIENCE LETTERS (2004)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
V Cochen et al.
MOVEMENT DISORDERS (2003)
Positron emission tomography quantification of [11C]-DASB binding to the human serotonin transporter:: Modeling strategies
N Ginovart et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
P Brundin et al.
BRAIN (2000)
Physical characteristics of the ECAT EXACT3D positron tomograph
TJ Spinks et al.
PHYSICS IN MEDICINE AND BIOLOGY (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
